SCHEMBL4919256

SCHEMBL4919256

Cc1ccc(S(=O)(=O)NCc2ccc(C(=O)NO)cc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.76
HDAC3 O15379 1/20 0.76
HDAC8 Q9BY41 1/20 0.76
LMNA P02545 2/20 0.72
TP53 P04637 1/20 0.72
HPGD P15428 2/20 0.70
MAPT P10636 3/20 0.65
MEN1 O00255 1/20 0.65
POLB P06746 1/20 0.65
KMT2A Q03164 1/20 0.65
ALDH1A1 P00352 4/20 0.63
NAMPT P43490 1/20 0.62
CA12 O43570 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
ATM Q13315 1/20 0.61
CA9 Q16790 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
OPRK1 P41145 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19358853 0.89 TP53 (0.81) LMNATP53HPGDMAPTMEN1
SCHEMBL4920512 0.86 HDAC6 (0.72) HDAC6HDAC3HDAC8LMNATP53
SCHEMBL12530914 0.85 TSHR (0.72) LMNATP53HPGDMAPTMEN1
SCHEMBL7403303 0.85 NPC1 (0.72) LMNATP53HPGDMAPTMEN1
SCHEMBL25547142 0.84 CA12 (0.83) LMNATP53HPGDMEN1KMT2A
SCHEMBL4928550 0.84 ALDH1A1 (0.70) HDAC6HDAC3HDAC8LMNATP53
SCHEMBL4916863 0.83 HDAC6 (0.76) HDAC6HDAC3HDAC8LMNATP53
SCHEMBL4927135 0.83 HDAC6 (0.68) HDAC6HDAC3HDAC8MAPTOPRK1
SCHEMBL20981410 0.83 ALDH1A1 (0.68) LMNATP53HPGDMAPTMEN1
SCHEMBL19358841 0.83 MEN1 (0.75) LMNATP53HPGDMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US claimed
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US disclosed
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US disclosed
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 HDAC6 2092/4885HDAC3 3274/4885HDAC8 3399/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 HDAC6 2060/4885HDAC3 3414/4885HDAC8 3570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.